2025年, " 维持生命健康 " 盈利,净收入为9.7亿美元,收入为1.424B美元,增长强劲,股票回购1亿美元。 LifeStance Health turned profitable in 2025, reporting $9.7M net income and $1.424B revenue, with strong growth and a $100M stock buyback.

生命保障健康小组报告说,2025年,它作为一家公营公司首次获得年度盈利,净收入为970万美元,收入为14.24亿美元,年年增长14%,其驱动因素是访问量增加和诊所增长。 LifeStance Health Group reported its first annual profitability as a public company in 2025, posting net income of $9.7 million and revenue of $1.424 billion, a 14% increase year-over-year, driven by higher visit volumes and clinician growth. 该公司实现了创纪录的第四季度经调整的EBITDA4 900万美元,增长了49%,并宣布了一项1亿美元份额回购方案。 The company achieved record fourth-quarter Adjusted EBITDA of $49 million, up 49%, and announced a $100 million share repurchase program. 2026年,生命系统预测收入在16.15亿至16.55亿美元之间,经调整的欧洲-太平洋开发协会(EBITDA)收入为1.85亿至2.05亿美元,原因是业务不断改进、AI驱动的增效以及新的电子健康记录系统。 For 2026, LifeStance projected revenue between $1.615 billion and $1.655 billion, with adjusted EBITDA of $185 million to $205 million, citing ongoing operational improvements, AI-driven efficiency gains, and a new electronic health record system.